OrbiMed’s Spruce Biosciences SPRB Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRB
ACM
OrbiMed's SPRB Position: Q3 2026 in Review
OrbiMed increased its Spruce Biosciences (SPRB) stake by 21% in Q3 2026, buying an estimated $2.17M and bringing the position to 242,800 shares worth $11.8M. The position accounts for 0.21% of the portfolio, ranked #81.
OrbiMed first reported a position in SPRB in Q2 2026 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.
- OrbiMed held 242,800 shares of Spruce Biosciences worth $11.8M as of Q3 2026.
- OrbiMed bought 42,800 Spruce Biosciences shares in Q3 2026, an estimated $2.17M.
- Spruce Biosciences made up 0.21% of OrbiMed's portfolio in Q3 2026, its #81 holding.
- OrbiMed first reported a position in Spruce Biosciences in Q2 2026 and has held it in 2 quarters since.
- 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.